Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-02

Clinical Trial Update: Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intra-arterial melphalan for advanced intraocular retinoblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melphalan (Melphalan)

Snippet

Sponsor: Hospital Sant Joan de Deu | Conditions: Retinoblastoma | Phase 2 | Status: TERMINATED